Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2021
Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic MiceNeha Nandedkar-Kulkarni, Emily Esakov, Brigid Gregg, et al.Diabetes Care|September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to PreventionEmily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adultsErin L Templeman, Nick Thomas, Susan Martin, et al.Diabetes|August 28, 2025
Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time IntervalEmily K Sims, William E Russell, David Cuthbertson, et al.Diabetes Care|May 6, 2026
Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive AdultsErin L Templeman, Nick Thomas, Susan Martin, et al.Diabetes|December 10, 2025
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and ProgressionTaylor M Triolo, Jay M Sosenko, David Cuthbertson, et al.Hormone Research in Paediatrics|December 11, 2024
ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 DiabetesMichael J Haller, Kirstine J Bell, Rachel E J Besser, et al.Journal for Immunotherapy of Cancer|August 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreasZoe Quandt, Arabella Young, Graham Larson Barlow, et al.Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.Biorxiv : the Preprint Server for Biology|May 20, 2024
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.Pageof 11